Heron Therapeutics | HRTX - Action





Action Changement Date
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amarin USD 164.07M 19.51M 2026-06
ANI Pharmaceuticals USD 143.15M 319K 2026-06
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
Eisai JPY 257.55B 21.09B 2026-03
Emergent BioSolutions USD 328.9M 25.2M 2023-12
GlaxoSmithKline GBP 6.16B 233M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 142.38M 9.48M 2026-06
Ligand Pharmaceuticals USD 10.26M 3M 2026-06
Merck USD 6.21B 272M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Omeros USD 712K 266K 2021-09
Pacira USD 134.57M 15.8M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Veracyte USD 22.66M 1.24M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06